Interferon regulatory factor 3 (IRF3) and type I interferons (IFNs) protect against infections 1 and cancer 2 , but excessive IRF3 activation and type I IFN production cause autoinflammatory conditions such as Aicardi-Goutières syndrome 3, 4 and STINGassociated vasculopathy of infancy (SAVI) 3 . Myocardial infarction (MI) elicits inflammation 5 , but the dominant molecular drivers of MI-associated inflammation remain unclear. Here we show that ischemic cell death and uptake of cell debris by macrophages in the heart fuel a fatal response to MI by activating IRF3 and type I IFN production. In mice, single-cell RNA-seq analysis of 4,215 leukocytes isolated from infarcted and non-infarcted hearts showed that MI provokes activation of an IRF3-interferon axis in a distinct population of interferon-inducible cells (IFNICs) that were classified as cardiac macrophages. Mice genetically deficient in cyclic GMP-AMP synthase (cGAS), its adaptor STING, IRF3, or the type I IFN receptor IFNAR exhibited impaired interferon-stimulated gene (ISG) expression and, in the case of mice deficient in IRF3 or IFNAR, improved survival after MI as compared to controls. Interruption of IRF3-dependent signaling resulted in decreased cardiac expression of inflammatory cytokines and chemokines and decreased inflammatory cell infiltration of the heart, as well as in attenuated ventricular dilation and improved cardiac function. Similarly, treatment of mice with an IFNAR-neutralizing antibody after MI ablated the interferon response and improved left ventricular dysfunction and survival. These results identify IRF3 and the type I IFN response as a potential therapeutic target for post-MI cardioprotection.
MI causes massive synchronous cell death in the heart and catastrophically releases damage-associated molecular patterns (DAMPs) that stimulate the innate immune response. Although the molecular nature of the dominant MI-induced DAMPs remains undefined, these DAMPs are thought to be sensed by Toll-like receptors (TLRs) of infiltrating cells and to fuel post-MI inflammation, by both activating the transcription factor nuclear factor (NF)-κB and inducing the proinflammatory cytokines tumor necrosis factor (TNF)-α, pro-IL-1β, and IL-6 (refs. 6, 7) . Unfortunately, despite the association between inflammation and poor clinical outcomes, efforts to limit post-MI and heart-failureassociated inflammation with steroidal or non-steroidal anti-inflammatory drugs that target NF-κB-dependent signaling have failed to show benefit 8 . Thus, an improved molecular understanding of MI danger signaling might enable more effective post-MI cardioprotection 8 .
Cytosolic nucleic acid sensors initiate TLR-independent responses that protect against infection by invading pathogens 1, 9 . For example, during viral or intracellular bacterial infection, the cytosolic DNA sensor cGAS detects pathogen DNA 10 and catalyzes synthesis of the cyclic dinucleotide cGAMP 11 , which signals via the adaptor STING 12 , facilitates TBK1-dependent IRF3 activation 13 , and orchestrates a gene expression program characterized by IFN-β production and type I IFN response. Meanwhile, DNA abounds in every mammalian cell, but spontaneous self-stimulation is avoided through nuclear and mitochondrial compartmentalization 14 and through enzymatic digestion of self-DNA by patrolling endosomal and cytosolic DNases 15, 16 . We hypothesized that the high levels of ischemic cell death during MI may disrupt DNA sequestration and liberate large quantities of self-DNA for cytosolic sensing, ultimately fueling a maladaptive IRF3dependent innate immune response. To test this hypothesis, we studied IRF3 and the type I IFN response following permanent coronary ligation (MI) in mice.
Because IRF3 and type I IFNs lack established roles in ischemic heart disease, we first evaluated whether IRF3 is activated by MI in wild-type (WT) mice. Despite the absence of infection in this setting, IRF3 and type I interferons fuel a fatal response to myocardial infarction we detected increased levels of phosphorylated IRF3 ( Fig. 1a and  Supplementary Fig. 1a ) and robust induction of prototypical IRF3dependent cytokines (Ifnb1) and chemokines (Cxcl10) (Fig. 1b,c ) on day 4 after MI; the increase in Ifnb1 levels was detected as early as day 1 after MI ( Supplementary Fig. 1b) . In contrast to WT mice, IRF3-knockout (Irf3 −/− ) mice showed almost complete abrogation of the MI-induced type I IFN response (Fig. 1b,c) . Type I IFNs such as IFN-β1 (encoded by Ifnb1) amplify immune responses by binding to cell-surface IFN-α receptors (encoded by Ifnar1, referred to hereafter as Ifnar), leading to induction of diverse effectors known as ISGs. Consistent with this concept, we detected marked increases in the levels of many ISGs in WT mice but negligible induction in comparably treated Irf3 −/− mice on day 4 after MI ( Fig. 1d) . By comparison, Irf3 deficiency had a less severe effect on mRNAs encoding prototypical NF-κB-dependent inflammatory cytokines, such as Tnf, Il1b, and Il6 (Supplementary Fig. 2 ). Genome-wide expression profiling of WT and Irf3 −/− mice using RNA-seq confirmed these findings and showed that ISGs were among the most highly differentially expressed genes after MI (P < 1 × 10 −12 , hypergeometric test) ( Fig. 1e and Supplementary Fig. 3 ).
To determine whether the interferon response is a specialized function of specific cells in the infarct, we performed single-cell RNA-seq profiling of 4,215 cells using microfluidic inDrop barcoding (n = 1,858 and n = 1,654 CD45 + sorted infarct leukocytes from post-MI day 4 WT and Irf3 −/− hearts, respectively, and n = 703 unsorted cells from the ventricular apex of non-infarcted WT hearts). Unbiased clustering of the cells from post-MI WT hearts identified a unique population of IFNICs closely associated with mononuclear cell clusters ( Fig. 1f) . On the basis of analysis of marker gene expression as well as calculation of an IRF3 score, defined as the summed expression of three validated directly IRF3-dependent genes (Ifit1, Ifit2, and Ifit3), the IFNICs were identified as cells with specialized expression of ISGs and directly IRF3-dependent genes (Fig. 1g,h and Supplementary Tables 1-7) 17, 18 . In contrast, we did not detect IFNICs by single-cell analysis of post-MI day 4 Irf3 −/− infarcts or non-infarcted WT hearts ( Supplementary Fig. 4 ).
Next, we explored which cell populations account for IRF3-dependent gene expression after MI using FACS. Cells were sorted from the infarcted region at day 4 on the basis of cell-surface CD45 or CD11b staining and were assessed for expression of IRF3-dependent genes. CD45 + and CD11b + subpopulations, but not CD45 − or CD11b − subpopulations, reliably expressed Ifnb1 ( Fig. 2a,b) . Parabiosis experiments, in which Irf3 −/− mice underwent coronary artery ligation after having been paired with either WT or Irf3 −/− mice, showed that, after MI, there was significantly increased expression of IRF3-dependent genes in the presence of circulating cells that entered the heart (Fig. 2c) . These data indicate that IFNICs are derived from blood.
To study how IRF3-dependent responses are initiated after MI, we created a reporter mouse (Myh6-Cre +/-mTmG +/+ ; referred to as Cre + ) in which only cardiomyocytes express membrane EGFP (green), whereas all non-cardiomyocytes express membrane tdTomato (red). This was compared to Cre-deficient controls (Myh6Cre −/− mTmG +/+ ; referred to as Cre − ) 19 . This approach enabled us to identify infiltrating cells with the greatest exposure to cardiomyocyte-derived DAMPs (red cells with green fluorescence above background). On day 4 after MI, we isolated CD11b + cells associated with cardiomyocyte debris by gating on red cells with EGFP fluorescence levels above a stringently defined background in Cre − mice ( Fig. 2d-h and Supplementary  Fig. 5 ). This CD11b + EGFP + population consisted almost exclusively of F4/80 hi Ly6C lo cells (macrophages), which we term post-phagocytic macrophages ( Fig. 2f) . These CD11b + EGFP + cells expressed significantly more Ifnb1 than CD11b + EGFP − cells (Fig. 2g) . In contrast, the two CD11b + cell populations expressed similar amounts of ISGs ( Fig. 2h) . Together, these results indicate that DAMP sensing by infarct phagocytes leads to type I IFN production, which secondarily induces ISG expression in nearby cells, regardless of their direct association with the initiating cardiomyocyte DAMP.
To visualize the spatial distribution of interferon-responsive cells, we created an interferon-inducible reporter mouse (Mx1Cre mTmG) expressing membrane tdTomato (red) in all cells except those induced to express Cre recombinase by endogenous activation of the interferonsensitive Mx1 promoter, which changes reporter expression to membrane EGFP (green) 4, 19 . On day 4 after MI, reporter mice exhibited dense accumulation of green interferon-responsive cells throughout the infarct zone ( Fig. 2i) . However, no green interferon-responsive cells had the morphology typical of a sarcomere-containing cardiomyocyte, suggesting that non-myocytes are the interferon-responsive cell type.
We next investigated whether the interferon response impacted the extent and quality of immune cell infiltrate. Immunohistochemical staining and multiphoton autofluorescence microscopy showed reduced accumulation of leukocytes in the border-zone region in Irf3 −/− as compared to WT mice at day 4 after MI ( Fig. 2j and Supplementary  Fig. 6a,b ). Using flow cytometry, we found that the decreased amount of infarct infiltrate in Irf3 −/− in comparison to WT mice resulted from a decrease in the F4/80 lo Ly6C hi proinflammatory monocyte population ( Fig. 2k) . By comparison, the size of the F4/80 hi Ly6C lo phagocytic macrophage population was only modestly affected. These observations are consistent with findings that the hearts of Irf3 −/− mice, in comparison to WT mice, had decreased mRNA expression of cell-surface leukocyte adhesion molecules and leukocyte-recruitment chemokines, which facilitate leukocyte infiltration of the infarct ( Supplementary  Fig. 6c,d ). Next, we examined expression in our single-cell RNA-seq data of cell-surface markers for mononuclear cells recently linked to ontologic and phenotypic subsets of leukocytes. This analysis identified IFNICs as cells expressing Adgre1 (encoding F4/80), H2.Aa (encoding major histocompatibility complex type II (MHCII)), and Ccr2, but not expressing Ly6c2 (encoding Ly6C) ( Fig. 2l) , and hence classified IFNICs as monocyte-derived cardiac macrophages 20 . This cell population was not identifiable by analysis of the single-cell RNA-seq data derived from leukocytes of Irf3 −/− mice or WT sham controls ( Supplementary  Fig. 4c,d) . Taken together, these results suggest that interactions of infarct phagocytes with cardiomyocyte debris fuel IRF3-dependent leukocyte recruitment and amplify inflammation after MI.
We next sought to determine the dominant DAMP responsible for MI-induced IRF3 activation. Three adaptor proteins can activate IRF3 (ref. 21): TIR-domain-containing adaptor inducing interferon beta (TRIF) 22 , mitochondrial antiviral signaling protein (MAVS) 23 , and stimulator of interferon genes (STING) 12, 24 (Fig. 3a) . By subjecting mice functionally deficient in each adaptor to MI, we found that Sting gt/gt mice with a mutagenized Sting (Tmem173) gene most closely replicated the Irf3 −/− post-MI expression pattern: as compared to WT mice, Sting gt/gt mice showed reduced Ifnb1 expression and almost complete abrogation of Cxcl10, Irf7, and Ifit1 expression despite having no significant decreases in the expression of cytosolic-DNA-sensing molecules ( Fig. 3b and Supplementary Fig. 2e-i) .
Cytosolic double-stranded DNA (dsDNA) is the only endogenous DAMP known to activate IRF3 via the adaptor STING. It does so via the DNA sensor cGAS (Fig. 3c) . Indeed, mice null for Mb21d1 (hereafter referred to as cGAS −/− mice) 10 , like Irf3 −/− and Sting gt/gt mice, did not exhibit significant induction of the type I IFN response after MI ( Fig. 3d) . Similarly, Ifnar −/− mice lacking the type I IFN receptor also showed no induction of the interferon response after MI ( Fig. 3d) . Furthermore, we observed substantial overlap between the genes most differentially expressed in WT as compared to Irf3 −/− mice after MI and those previously found to be induced by mitochondrial DNA release 14 , bacterial DNA secretion 25 , or DNA accumulation due to absence of endogenous DNase activity 16, 26 (Supplementary Fig. 3c,d) . Taken together, these results are consistent with the concept that the cytosolic-DNA-sensing pathway is responsible for induction of an IRF3-dependent type I IFN response in the heart after MI; however, other pathways may also contribute.
To determine whether ischemic injury disrupts intracellular compartmentalization and makes cardiomyocyte DNA available for sensing, we performed an ischemia-reperfusion procedure in which mice were subjected to 20 min of coronary ligation followed by reperfusion; the restoration of flow was used to allow delivery of DNA-bindingdependent fluorescent probe, PicoGreen or SYTOX Orange. Using gated intravital microscopy in the beating heart, we found that the DNA probes localized exclusively to the nuclei of intact surviving cells, whereas they spread throughout the cytosol of injured cells (Fig. 3e,f and Supplementary Fig. 7 ).
Next, we devised an experiment to determine whether infiltrating cells access cardiomyocyte DNA in the infarct in vivo. Cardiomyocyte DNA was indelibly labeled in utero by injecting pregnant mice with the modified nucleotide 5-ethynyl-2′-deoxyuridine (EdU). When the offspring grew to adults, the location of covalently DNA-bound EdU was visualized by bio-orthogonal click chemistry. Cardiomyocytes, which proliferate rapidly in utero but minimally in adulthood, retained the label in adult mice, whereas highly proliferative hematopoietic cells and their leukocyte progeny diluted EdU to undetectable levels ( Fig. 3g ) 27 . When we challenged the labeled mice with MI, we found that EdU localized to the extranuclear space of infiltrating borderzone cells on day 4 after MI but was not detectable in circulating cells from cytospun blood. For comparison, when we exposed bone marrow-derived macrophages in vitro to EdU-labeled DNA extracted from the heart, we observed a similar distribution of EdU labeling of the macrophages, together with induction of type I IFN and ISG expression ( Fig. 3h and Supplementary Fig. 8 ). Bone marrow-derived macrophages from WT mice strongly expressed type I IFNs in response to DNA. Macrophages from cGAS-, STING-, or IRF3-deficient mice were unable to mount a similar response (Supplementary Fig. 9 ). Taken 
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Relative expression (fold change) together, these results indicate that macrophages can access extracellular DNA and produce type I IFNs in a cGAS-, STING-, and IRF3dependent fashion. Together, these findings suggest that ischemic cells in the heart release DNA that provokes infarct phagocytes to induce a cGAS-and IRF3-dependent type I IFN response.
To determine the functional significance of MI-induced IRF3 activation, we compared survival, ventricular remodeling, and contractile function after MI between WT mice and mice with impaired interferon signaling. Despite closely matched baseline echocardiographic parameters and magnetic resonance imaging (MRI)-assessed infarct sizes (Supplementary Fig. 10a-d) , we observed substantial differences in ventricular remodeling and survival between WT mice and Irf3 −/− , Ifnar −/− , or cGAS −/− mice (Fig. 4a-l) . Consistent with prior reports 28 , 61% (35/57) of WT male mice survived after MI; these mice showed ventricular dilation and rupture from days 4-6 after MI ( Fig. 4a-d) . In contrast, Irf3 −/− and Ifnar −/− mice showed virtually complete protection from death, with 98% (44/45) and 100% (31/31) survival, respectively, over the 2 weeks of observation following coronary artery occlusion. cGAS −/− mice also showed significant, although less striking, protection (82% survival; 39/47). In contrast, Sting gt/gt mice showed a non-significant increase in survival (77%; 24/31) ( Supplementary Fig. 11 ), suggesting that other innate immune sensors might also participate in IRF3 activation after MI. We also evaluated the effects of interferon signaling on ventricular dilation and contractile function, parameters that in humans predict symptoms and outcomes in heart failure. Longitudinal assessment of ventricular size at days 4, 7, and 21 after MI showed less dilation of Irf3 −/− mice as compared to WT mice (Supplementary Fig. 12 ). Echocardiographic and cardiac MRI evaluation on days 4 and 21 after MI showed significantly less chamber dilation and greater preservation of contractile function in cGAS −/− , Irf3 −/− , and Ifnar −/− mice as compared to WT mice (Fig. 4b-l) . No substantial differences in coronary vascular anatomy, spontaneous reperfusion, or recruitment of collateral vessels could be identified between WT and Irf3 −/− mice to explain the differences in ventricular dilation, contractile function, and survival ( Supplementary Fig. 10e,f) .
To test the translational potential of these findings, we treated WT mice with an IFNAR-neutralizing antibody at 12 and 48 h after MI. Antibody treatment abrogated ISG expression and improved ventricular size, contractile function, and survival ( Fig. 4m-p) , demonstrating that transient inhibition of the interferon response, initiated after coronary occlusion, can protect the recently infarcted ventricle.
In summary, these findings highlight the concept that a response that is protective in the context of pathogen defense has deleterious consequences in the context of sterile ischemic injury. According to our working model (Fig. 4q) , MI causes ischemic cell death in the heart, releasing debris from dying cells including danger signals such as dsDNA. Infiltrating cells such as phagocytic macrophages sense DNA via the cytosolic sensor cGAS, leading to activation of the transcription factor IRF3 and induction of the IRF3-dependent gene expression program, which includes type I IFNs. Secreted type I IFNs can then diffuse through the local microenvironment and signal to cells expressing IFNAR, in both an autocrine and paracrine fashion, to amplify the response via expression of ISGs. In comparison to WT mice after MI, mice with genetic deficiency of cGAS, IRF3, or IFNAR, or those treated with an IFNAR-neutralizing antibody, exhibit less ventricular dilation, greater preservation of contractile function, less ventricular rupture, and greater survival. Therapeutically, cancer immunotherapy and vaccine adjuvants aim to boost innate immunity [29] [30] [31] . Here we suggest that transient inhibition of the interferon-dependent innate immune response to ischemic cell death could reduce inflammation and limit the adverse ventricular remodeling that leads to clinical heart failure. Humans tolerate the anti-interferon biologics that are in clinical development for rheumatologic indications [32] [33] [34] , suggesting the feasibility of targeting the interferon response in MI. The profound effects of IRF3 and the type I IFN response on inflammation and ventricular remodeling after MI expand the role of this response beyond host defense and autoimmunity and support its exploration as a new target for post-MI cardioprotection.
MeTHodS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
oNLINe MeTHodS
Mice. Adult C57BL/6J (WT; stock 000664), type I IFN-inducible Cre-expressing B6.Cg-Tg(Mx1-cre)1Cgn/J (Mx1-cre; stock 003556) 19 , B6.FVB-Tg(Myh6cre)2182Mds/J with cardiomyocyte-specific Cre expression (Myh6-cre; stock 011038), Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo /J (mTmG; stock 007576) 35 , MAVS-deficient B6;129-Mavs,tm1Zjc>/J (Mavs −/− ; stock 008634) 36 , C57BL/6J-Ticam1 Lps2 /J with functionally deficient TRIF (Trif Lps2/Lps2 ; stock 005037) 37 , and C57BL/6J-Tmem173<gt>/J with functionally deficient STING (Sting gt/gt ; stock 017537) 24 mice were purchased from the Jackson Laboratory. cGASdeficient (cGAS −/− ) mice were either B6(C)-Mb21d1,tm1d(EUCOMM)Hmgu>/J mice purchased from the Jackson Laboratory (stock 026554) or were from the laboratory of K.A.F. after derivation from cryopreserved embryos obtained from the European Conditional Mouse Mutagenesis Program (EUCOMM). Irf3 −/− mice 38 were a generous gift from T. Taniguchi (Tokyo University) and provided by M. Diamond (Washington University School of Medicine). IFNAR-knockout (Ifnar −/− ) mice were originally from J. Sprent and were backcrossed for 12 generations at the University of Massachusetts Medical School and provided by K.A.F. Genotyping was performed in house using methods recommended by Jackson Laboratory or Transnetyx. All experiments were performed with 10-to 25-week-old animals and were carried out using ageand sex-matched groups without randomization. All mice were maintained in a pathogen-free environment at the Massachusetts General Hospital and University of Massachusetts animal facilities, and all animal experiments were approved by the Subcommittee on Animal Research Care at Massachusetts General Hospital or the University of Massachusetts.
Myocardial infarction and cardioprotective therapy.
Mice were intubated and ventilated with 2% isoflurane. After exposing the heart via thoracotomy at the fourth left intercostal space, the left coronary artery was permanently ligated with an 8-0 nylon monofilament suture. The thorax was closed with a 5-0 suture. Mice were given buprenorphine as an analgesic on the day of surgery and twice daily thereafter for 72 h. For cardioprotection experiments, mice were administered two intraperitoneal doses of 500 µg of MAR1-5A3 IFNAR-neutralizing antibody (BioXCell) at 8-12 h and 48 h after permanent coronary ligation. Surgeries were performed with blinding to genotype unless genotype was obvious from unavoidable ascertainment of features such as coat color.
Parabiosis.
Mice were joined in parabiosis as previously described 39 . Mice were anesthetized with 2% isoflurane (2 L/min O 2 ). Briefly, after shaving the corresponding lateral aspects of each mouse, matching skin incisions were made from behind the ear to the tail of each mouse and the subcutaneous fascia was bluntly dissected to create ~0.5 cm of free skin. The scapulas were sutured using mono-nylon 5.0 (Ethicon), and the dorsal and ventral skins were approximated by continuous suture. All mice undergoing parabiosis surgeries were injected twice daily with buprenorphine (0.1 mg per kg body weight intraperitoneally) for 3 d beginning on the day of surgery. Mice were joined for intervals of 2 weeks before proceeding with coronary ligation.
Blood and heart tissue processing. Blood was collected by cardiac puncture. The cellular fraction was collected into EDTA-containing tubes (Sigma), and erythrocytes were eliminated using red blood cell (RBC) lysis buffer (BioLegend). Heart tissue was collected by incising the right atrium and perfusing 10 ml of ice-cold saline into the left ventricular apex. Heart tissue was then removed and used for one of several assays detailed below. It was either imaged grossly, embedded in OCT (Sakura, Finetek) for frozen sectioning and immunohistochemical staining, placed in RNAlater (Qiagen) for RNA extraction and gene expression analysis, snap frozen in liquid nitrogen for protein analysis, fixed for 2 h in 4% paraformaldehyde for whole-mount immunofluorescence staining, or freshly cut into short-axis sections using a commercial heart slicer (Zivic Instruments) and placed between glass coverslips for immediate ex vivo imaging of genetically encoded fluorescence or endogenous autofluorescence. To obtain single-cell suspensions for surface immunostaining, flow cytometry analysis, and FACS sorting, hearts were enzymatically digested for 1 h under continuous agitation in 450 U/ml collagenase I, 125 U/ml collagenase XI, 60 U/ml DNase I, and 60 U/ml hyaluronidase (Sigma) for 1 h at 37 °C and filtered through 40-µm nylon mesh in FACS buffer (DPBS with 2.5% BSA) for enumeration by flow cytometry. For single-cell RNA-seq, the enzymatic digestion was limited to 45 min.
Flow cytometry and cell sorting. Cells isolated from enzymatically digested hearts were stained at 4 °C in FACS buffer for mouse hematopoietic lineage markers, using PE-or avidin-conjugated anti-mouse antibodies directed against B220 (BioLegend, clone RA3-6B2), CD49b (BioLegend, clone DX5), CD90.2 (BioLegend, clone 53-2.1), Ly6G (BioLegend, clone 1A8), NK1.1 (BioLegend, clone PK136), and Ter119 (BioLegend, clone TER-119). Secondary staining of leukocyte subsets was performed using antibodies to CD11b (BioLegend, clone M1/70), CD11c (BioLegend, clone N418), CD45.2 (BioLegend, clone 104), F4/80 (BioLegend, clone BM8), and/or Ly6C (BioLegend, clone HK1.4 or BD Bioscience, clone AL-21). Neutrophils were identified as (B220/CD49b/ CD90.2/Ly6G/NK1.1/Ter119) hi (CD45.2/CD11b) hi . Monocytes were identified as (B220/CD49b/CD90.2/Ly6G/NK1.1/Ter119) lo (CD45.2/CD11b) hi and subclassified as proinflammatory monocytes (F4/80 lo Ly6C hi ) or macrophages (F4/ 80 hi Ly6C lo/int ). Flow cytometry was performed on an LSRII (BD Biosciences) and data were analyzed with FlowJo software (Tree Star). Single cells from specific populations were collected for subsequent bimolecular analysis by FACS sorting using a FACSAria II cell sorter (BD Biosciences). Single-cell RNA-seq samples were stained with Hoechst to exclude dead cells. Non-infarcted samples were unsorted. Infarcted samples were sorted for CD45 + cells only.
Quantitative real-time PCR. Total RNA was extracted from whole-infarct tissue and FACS sorted cells using the RNeasy Mini and Micro kits (Qiagen), respectively, according to the manufacturer's protocol. First-strand cDNA was synthesized using the High-Capacity RNA-to-cDNA kit (Applied Biosystems) according to the manufacturer's instructions. TaqMan gene expression assays (Applied Biosystems) were used to quantify target genes (Ifnb1, Mm00439546_ s1; Cxcl10, Mm00445235; Irf7, Mm00516793_g1; Ifit1, Mm00515153_m1; Ifit2, Mm00492606_m1; Ifit3, Mm01704846_s1; Oasl2, Mm01201449_m1; Rsad2, Mm00491265_m1; Tnf, Mm00443258_m1; Il1b, Mm00434228_m1; Il6, Mm00446190_m1; Mb21d1, Mm01147496_m1; Tmem173, Mm01158117_m1; Irf3, Mm00516784_m1; Ifnar2, Mm00494916_m1). Relative changes in expression were normalized to Gapdh mRNA using the 2 −∆∆Ct method.
Genome-wide RNA sequencing and analysis. Total RNA from infarct tissue was isolated from WT and Irf3 −/− mice on day 4 after MI. RNA-seq libraries were constructed from poly(A)-selected RNA using the NEBNext Ultra Directional RNA library prep kit (Illumina, New England BioLabs) and sequenced on an Illumina HiSeq 2500 instrument, resulting in approximately 41 million reads per sample on average. Transcriptome mapping was performed with STAR version 2.3.0 (ref. 40) using the Ensembl 67 release exon/splice junction annotations. Approximately 70-80% of reads mapped uniquely. Read counts for individual genes were produced using the unstranded count feature in HTSeq v.0.6.0 (ref. 41) . Differential expression analysis was performed using the exactTest routine of the edgeR package 42 after normalizing read counts and excluding genes with low counts (counts per million (CPM) < 1 for three or more samples) 43 . Differentially expressed genes were defined on the basis of meeting criteria of a >2-fold change in expression value and FDR < 0.05. Functional annotation was performed using Qiagen's Ingenuity Pathway Analysis ( Supplementary  Fig. 2a ) (http://www.giagen.com/ingenuity/) and the DAVID tool ( Supplementary Fig. 2b) 44, 45 . Published studies implicating cytosolic DNA sensing as the primary immune stimulus 14, 16, 25, 26, 46, 47 were compared to the list of differentially expressed genes determined by RNA-seq analysis of WT and Irf3 −/− mice from which RNA was collected on day 4 after MI.
Microfluidic inDrop single-cell RNA-seq. Single-cell RNA-seq was performed by microfluidic inDrop encapsulation, barcoding, and library preparation, as previously described 48, 49 . Paired-end sequencing was performed on an Illumina HiSeq 2500 instrument. Low-level analysis, including demultiplexing, mapping to a reference transcriptome (Ensembl release 85, GRCm38. p5), and eliminating redundant UMIs, was performed according to custom inDrops software (https://github.com/indrops/indrops; accessed April 2017).
Mitochondrial, ribosomal, and hemoglobin genes were depleted bioinformatically, and clustering, dimension reduction, and visualization were performed using the Seurat v1.4 software package in R with the following customization 50 . We considered cells expressing at least 200 genes, scaled to a total of 1 × 10 4 total molecules per cell, and log normalized the data. The gene space was limited to overdispersed high-variability genes. Linear dimension reduction was performed with principal-component analysis. Unsupervised clustering was performed according to the default Seurat implementation of a community detection approach. Marker gene sets and associated P values were determined by differential expression using the Seurat implementation of the likelihood-ratio test based on zero-inflated data. Cell and cluster proximity were visualized by projecting onto a 2D space using tSNE. Clusters were visualized using heat maps of genes × clustered single cells and violin plots depicting expression probability densities for each cluster. To determine single-cell IRF3 scores, we summed counts for the directly IRF3-dependent genes Ifit1, Ifit2, and Ifit3.
analysis was performed offline using EchoPAC PC software (GE Healthcare, version 113). LVIDd and LVIDs were measured at the maximal and minimal diameters, respectively, acquired from the parasternal short-axis images at a level selected for visualization of the papillary muscle. FS was determined by calculating the change in left ventricular internal dimensions between end diastole and end systole normalized to the end-diastolic dimension (LVIDd -LVIDs)/LVIDd. Cardiac magnetic resonance imaging. Cardiac MRI was performed on days 1 and 21 after coronary ligation. Cine images of the left ventricular short axis were obtained using a 7 Tesla horizontal bore Pharmascan (Bruker) and a custom-built mouse cardiac coil in birdcage design (Rapid Biomedical). Acquisition was electrocardiography triggered and respiratory gated using a fast low-angle shot sequence. The echo time was 2.7 ms, and the flip angle was 30° (60° for delayed enhancement imaging after intravenous injection of Gd-DTPA for measurement of infarct size). Images were analyzed using Segment software (http://medviso.com/products/segment). Infarct size was determined by summing the percentage myocardial mass enhanced by gadolinium on serial short-axis sections quantified at end diastole. The ejection fraction was determined by calculating the change in ventricular volume between end diastole and end systole normalized to the end-diastolic volume.
Statistics. Statistical analysis was performed using GraphPad Prism software. All data are represented as mean values ± s.e.m. unless indicated otherwise. A statistical method was not used to predetermine sample size. For two-group comparisons, a two-tailed Student's t test was applied if the D' Agostino-Pearson normality test was not rejected at a significance; level of 0.05; otherwise, a twotailed Mann-Whitney U test for nonparametric data was used. All analyses except those for sorted cells were unpaired. For sorted cell samples, paired analysis was used to compare subpopulations from each mouse. For survival studies, mice dying within 24 h of LAD ligation surgery (<10% in all genotypes studied) were prespecified as purely technical failures and excluded from subsequent analysis per protocol. The statistical significance of Kaplan-Meier survival curves was assessed with a Mantel-Cox test. P values less than 0.05 were considered to be significant and are indicated by asterisks as follows: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Data availability. Whole-infarct and single-cell RNA-seq data have been deposited to the Gene Expression Omnibus and are available under accession GSE106473. A Life Sciences Reporting Summary is available.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
